Cambridge Healthtech Institute’s Inaugural

Next-Generation Immunotherapies

Improving Safety & Efficacy

16 November 2023

New this year, the Next-Generation Immunotherapies conference examines the novel modalities and engineering strategies that are driving the future of immuno-oncology, immune disorders, and rare diseases. Topics include in vivo modification of cells, new constructs, designs, and MOAs, as well as considerations for the right/best approach for a specific disease or tumour type.

Coverage will include, but is not limited to:

In vivo Modification of Cells

Cell population & specificity
Rewiring T cells – logic gates, rewiring receptors, signaling, synthetic biology approaches
Epigenetic – modifiers of functional states, T cell short term memory vs other functional states

New Approaches and Platforms for Cancer Immunotherapy – Constructs, Design and Mechanisms of Action

Bispecific TCEs
Myeloid checkpoint molecules
Agonists
Vectorized cancer immunotherapies – mRNA, masked antibodies, immunocytokines, oncolytic virus, cancer vaccines
Cell-based immunotherapies – CARs, TILs, TCRs

Choosing The Best/Right Approach for Disease Targeting

mAb immune checkpoint blockade vs bispecific retargeting vs CAR Ts or a combination
Stage of disease, hot vs cold tumours, hematologic vs solid tumours

The deadline for priority consideration is 31 March 2023.

All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

Opportunities for Participation:

To submit a podium presentation, please click here.
To become a sponsor, click here.
To present a poster, click here.
To sign up to attend, click here

For more details on the conference, please contact:

Mimi Langley
Senior Conference Director
Cambridge Healthtech Institute
Phone: (+1) 781-972-5439
Email: mlangley@healthtech.com

For sponsorship information, please contact:

Companies A-K
Jason Gerardi
Sr. Manager, Business Development
Cambridge Healthtech Institute
Phone: (+1) 781-972-5452
Email: jgerardi@healthtech.com

Companies L-Z
Ashley Parsons
Manager, Business Development
Cambridge Healthtech Institute
Phone: (+1) 781-972-1340
Email: ashleyparsons@healthtech.com